Licheniocin 50.2 and bacteriocins from Lactococcus lactis subsp. Lactis biovar. Diacetylactis BGBU1-4 Inhibit Biofilms of coagulase negative staphylococci and Listeria monocytogenes clinical isolates

PLoS ONE

Volumn 11, Issue 12, 2016, Pages

  Cirkovic, Ivana ^a   Bozic, Dragana D ^b   Draganic, Veselin ^a   Lozo, Jelena ^b   Beric, Tanja ^b   Kojic, Milan ^b   Arsic, Biljana ^a   Garalejic, Eliana ^a   Djukic, Slobodanka ^a   Stankovic, Slavisa ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOCIN; LICHENIOCIN 50.2; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; LICHENIOCIN 50.2, LACTOCOCCUS LACTIS;

ARTICLE; BACTERIUM ISOLATE; BIOFILM; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; LACTOCOCCUS LACTIS SUBSP. LACTIS; LACTOCOCCUS LACTIS SUBSP. LACTIS BIOVAR. DIACETYLACTIS; LISTERIA MONOCYTOGENES; NONHUMAN; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS LUGDUNENSIS; BACILLUS LICHENIFORMIS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; LACTOCOCCUS LACTIS; METABOLISM; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; BACILLUS LICHENIFORMIS; BACTERIOCINS; BIOFILMS; HUMANS; LACTOCOCCUS LACTIS; LISTERIA MONOCYTOGENES; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; STAPHYLOCOCCUS HOMINIS; STAPHYLOCOCCUS LUGDUNENSIS;

EID: 85002824950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0167995     Document Type: Article

References (33)

1. Ivanov YB. Microbiological features of persistent nonspecific urethritis in men. J Microbiol Immunol Infect. 2007; 40(2): 157-161. PMID: 17446965
2. Tansarli GS, Kostaras EK, Athanasiou S, Falagas ME. Prevalence and treatment of aerobic vaginitis among non-pregnant women: evaluation of the evidence for an underestimated clinical entity. Eur J Clin Microbiol Infect Dis. 2013; 32(8): 977-984. doi: 10.1007/s10096-013-1846-4 PMID: 23443475
3. Borges SF, Silva JG, Teixeira PC. Survival and biofilm formation of Listeria monocytogenes in simulated vaginal fluid: influence of pH and strain origin. FEMS Immunol Med Microbiol. 2011; 62(3):315-320. doi: 10.1111/j.1574-695X.2011.00815.x PMID: 21569122
4. Stepanovic S, Vukovic D, Djukic S, Cirkovic I, Svabic-Vlahovic M. Long-term analysis of Listeria monocytogenes vaginal carriage frequency in Belgrade, Serbia. Acta Microbiol Immunol Hung. 2007; 54 (2):195-199. doi: 10.1556/AMicr.54.2007.2.9 PMID: 17899798
5. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002; 15(2):167-193. doi: 10.1128/CMR.15.2.167-193.2002 PMID: 11932229
6. Stewart PS. Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol. 2002; 292 (2):107-113. doi: 10.1078/1438-4221-00196 PMID: 12195733
7. Stewart PS, Costerton JW. Antibiotic resistance of bacteria in biofilms. Lancet. 2001; 358(9276):135-138. PMID: 11463434
8. Lawton EM, Ross RP, Hill C, Cotter PD. Two-peptide lantibiotics: a medical perspective. Mini Rev Med Chem. 2007; 7(12):1236-1247. PMID: 18220976
9. Cotter PD, Hill C, Ross RP. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol. 2005; 3(10):777-788. doi: 10.1038/nrmicro1273 PMID: 16205711
10. Piper C, Cotter PD, Ross RP, Hill C. Discovery of medically significant lantibiotics. Curr Drug Discov Technol. 2009; 6(1):1-18. PMID: 19275538
11. Ruíz FO, Pascual L, Giordano W, Barberis L. Bacteriocins and other bioactive substances of probiotic lactobacilli as biological weapons against Neisseria gonorrhoeae. Pathog Dis. 2015; 73(3):10.
12. Amer EI, Mossallam SF, Mahrous H. Therapeutic enhancement of newly derived bacteriocins against Giardia lamblia. Exp Parasitol. 2014; 146:52-63. doi: 10.1016/j.exppara.2014.09.005 PMID: 25300763
13. Cotter PD, Ross RP, Hill C. Bacteriocins - aviable alternative to antibiotics? Nat Rev Microbiol. 2013; 11(2):95-105. doi: 10.1038/nrmicro2937 PMID: 23268227
14. Hassan M, Kjos M, Nes IF, Diep DB, Lotfipour F. Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance. J Appl Microbiol. 2012; 113 (4):723-736. doi: 10.1111/j.1365-2672.2012.05338.x PMID: 22583565
15. Beric T, Stankovic S, Draganic V, Kojic M, Lozo J, Fira D. Novel antilisterial bacteriocin licheniocin 50.2 from Bacillus licheniformis VPS50.2 isolated from soil sample. J Appl Microbiol 2014; 116(3):502-510. doi: 10.1111/jam.12393 PMID: 24238327
16. Gajic O, Kojic M, Banina A, Topisirovic L. Characterization of natural isolate Lactococcus lactis subsp. lactis BGMN1-5, a strain producing two bacteriocins, cell wall-associated proteinase and showing clumping phenotype. Arch Biol Sci. 1999; 51: 69-78.
17. Kojic M, Fira D, Banina A, Topisirovic L. Characterization of the cell wall-bound proteinase of Lactobacillus casei HN14. Appl Environ Microbiol. 1991; 57(6):1753-1757. PMID: 16348511
18. Diep DB, Skaugen M, Salehian Z, Holo H, Nes IF. Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc Natl Acad Sci U S A. 2007; 104(7):2384-2389. doi: 10.1073/pnas.0608775104 PMID: 17284603
19. Clinical Laboratory Standards Institute (CLSI) 2007. Performance standards for antimicrobial susceptibility testing, 17th Informational Supplement. Approved Standard. CLSI document M100-S17. Wayne, PA, USA.
20. Van Reenen CA, Dicks LM, Chikindas ML. Isolation, purification and partial characterization of plantaricin 423, a bacteriocin produced by Lactobacillus plantarum. J Appl Microbiol. 1998; 84(6):1131-1137. PMID: 9717299
21. Stepanovic S, Vukovic D, Hola V, Di Bonaventura G, Djukic S, Cirkovic I, et al. Quantification of biofilm microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS. 2007; 115(8):891-899. doi: 10.1111/j.1600-0463.2007.apm- 630.x PMID: 17696944
22. Cotter PD. An 'Upp'-turn in bacteriocin receptor identification. Mol microbiol. 2014; 92(6):1159-1163. doi: 10.1111/mmi.12645 PMID: 24811684
23. Diep DB, Skaugen M, Salehian Z, Holo H, Nes IF. Common mechanism of target cell recognition and immunity for class II bacteriocins. Proc Natl Acad Sci U S A. 2007; 104(7):2384-2389. doi: 10.1073/pnas.0608775104 PMID: 17284603
24. Robichon D, Gouin E, Debarbouille M, Cossart P, Cenatiempo Y, Hechard Y. The rpoN (s54) gene from Listeria monocytogenes is involved in resistance to mesentericin Y105, an antibacterial peptide from Leuconostoc mesenteroides. J Bacteriol. 1997; 179(23):7591-7594. PMID: 9393729
25. Yang SC, Lin CH, Sung CT, Fang JY. Antibacterial activities of bacteriocins: application in foods and pharmaceuticals. Front Microbiol. 2014; 5:241. doi: 10.3389/fmicb.2014.00241 PMID: 24904554
26. Borges S, Barbosa J, Silva J, Teixeira P. Evaluation of characteristics of Pediococcus spp. to be used as a vaginal probiotic. J Appl Microbiol. 2013; 115(2):527-538. Epub 2013 May 16. doi: 10.1111/jam. 12232 PMID: 23611355
27. Aldunate M, Srbinovski D, Hearps AC, Latham CF, Ramsland PA, Gugasyan R, et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Front Physiol. 2015; 6:164. doi: 10.3389/fphys.2015. 00164 PMID: 26082720
28. Fan A, Yue Y, Geng N, Zhang H, Wang Y, Xue F. Aerobic vaginitis and mixed infections: comparison of clinical and laboratory findings. Arch Gynecol Obstet. 2013; 287(2):329-335. doi: 10.1007/s00404-012-2571-4 PMID: 23015152
29. Fraczek M, Piasecka M, Gaczarzewicz D, Szumala-Kakol A, Kazienko A, Lenart S, et al. Membrane stability and mitochondrial activity of human-ejaculated spermatozoa during in vitro experimental infection with Escherichia coli, Staphylococcus haemolyticus and Bacteroides ureolyticus. Andrologia. 2012; 44(5):315-329. doi: 10.1111/j.1439-0272.2012.01283.x PMID: 22348773
30. Božić DD, Milenković M, Ivković B,Ćirković I. Newly-synthesized chalcones-inhibition of adherence and biofilm formation of methicillin-resistant Staphylococcus aureus. Braz J Microbiol. 2014; 45(1):263-270. PMID: 24948943
31. Balaji K, Thenmozhi R, Pandian SK. Effect of subinhibitory concentrations of fluoroquinolones on biofilm production by clinical isolates of Streptococcus pyogenes. Indian J Med Res. 2013; 137(5):963-971. PMID: 23760384
32. Saising J, Dube L, Ziebandt AK, Voravuthikunchai SP, Nega M, Götz F. Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother. 2012; 56 (11):5804-5810. doi: 10.1128/AAC.01296-12 PMID: 22926575
33. Nishie M, Nagao J, Sonomoto K. Antibacterial peptides "bacteriocins": an overview of their diverse characteristics and applications. Biocontrol Sci. 2012; 17(1):1-16. PMID: 22451427